FDA Begins Reviews Under Continuous Marketing Application Pilot Program

FDA has started reviewing two applications under its continuing marketing application "Pilot 1" program, Office of New Drugs Director John Jenkins, MD, reported at the World Health Care Congress Jan. 27 in Washington, D.C